With respect to the molecular features of Borrmann types, Dai et al. analyzed HER2 positivity in Asian patients with advanced GC and observed that type III–IV tumors showed higher HER2 positivity than type I–II GC [23]. The gene discussed is ERBB2; the disease is gastric cancer.